PrasunK.JalalMD

Hepatology & Liver Transplantation

Stan and Sue Partee Chair in Hepatology, Abdominal Transplant Center, Baylor College of Medicine

Dr. Jalal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6620 Main St
Ste 1475
Houston, TX 77030
Phone+1 713-798-8100

Fax+1 713-798-4530

Dr. Prasun Jalal is a gastroenterologist in Houston, TX and is affiliated with multiple hospitals in the area, including Ben Taub General Hospital, Baylor St. Luke's Medical Center, and CHI St. Luke's Health-The Woodlands Hospital. He received his medical degree from Postgraduate Institute of Medical Education and Research, India and has been in practice 25 years. He specializes in hepatology & liver transplantation and is experienced in hepatology, non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis due to chronic viral hepatitis, and cirrhosis due to autoimmune hepatitis. He has more than 50 publications and over 500 citings.

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2006 - 2007
Zucker School of Medicine at Hofstra/NorthwellFellowship, Gastroenterology, 2003 - 2006
Royal College of Physicians, London, United KingdomFRCP, 1996 - 2001
Postgraduate Institute of Medical Education and Research, IndiaClass of 1994, MD

FRCP (London, UK), FACG, FASSLD, FASGE, AGAF
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

PubMed

2 citations
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study.
Francisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, Winston Dunn, Heer Mehta
Alimentary Pharmacology & Therapeutics. 2025-04-01
Moderate alcohol-associated hepatitis: A real-world multicenter study.
Francisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, Heer Mehta, Karen Muñoz
Hepatology Communications. 2025-04-01
Efficacy and Safety of 10-Day Versus 14-Day Bismuth-Containing Quadruple Therapy forEradication: A Systematic Review and Meta-Analysis.
Najam Gohar, Zoya Ejaz, Faizan Ahmed, Abdul Rafay Ahmed, Muhammad Abdullah Humayun
JGH Open. 2025-03-01

Tapering Corticosteroids in Severe Alcohol-Associated Hepatitis Appears SafeNovember 28th, 2024
Heart Health Symposium Focuses on Asian Indian Risk of Heart Attacks and Its PreventionDecember 14th, 2017
IDA Hosts Fundraiser in Aid of Indian IDC Charity ClinicDecember 7th, 2017

CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASEBAYLOR COLLEGE OF MEDICINE2024–2026
Intestinal Microbiota Transplantin Severe Alcohol associated HepatitisNatinal Institute of Health2022–Present
Early Diagnosis of Liver CancerDora Roberts FoundationPresent
MacDonald Research GrantBaylor St Luke Medical CenterPresent

Education and Scholarship Committee, International Liver Transplantation Society
Program Evaluation Committee, American Association for the Study of Liver Disease